A 12-week TRE intervention with 6-8h eating windows demonstrates potential benefits for HD patients by improving mitochondrial function and cognitive scores, though adherence challenges remain. Emergi...
Recent studies suggest time-restricted eating may offer neuroprotective benefits for Huntington’s disease by improving mitochondrial function and reducing oxidative stress. Emerging research indicat...
A clinical trial at UC San Diego investigates how time-restricted eating may slow Huntington’s disease progression by improving metabolic health and reducing neuroinflammation. Researchers launc...
A 12-week clinical trial investigates time-restricted eating’s safety and efficacy in early-stage Huntington’s disease, focusing on mitochondrial function and cognitive outcomes. Groundbre...
Recent studies reveal TRE’s potential to enhance mitochondrial function and autophagy in neurodegenerative diseases, while highlighting risks for advanced Huntington’s patients. Emerging r...
New research explores how fasting may improve mitochondrial function and reduce oxidative stress in Huntington’s disease, with implications for other neurodegenerative conditions. Recent clinica...
Exploring a 12-week clinical trial protocol for time-restricted eating in early-stage Huntington’s disease, focusing on mitochondrial function, autophagy, and cognitive improvements. A new 12-we...
Recent studies explore how time-restricted eating may reduce protein aggregation in Huntington’s disease, with implications for Alzheimer’s and Parkinson’s treatment. Emerging resear...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A groundbreaking clinical trial investigates time-restricted eating for Huntington’s disease, exploring neuroprotective mechanisms and practical implementation for patients. The TREAT-HD trial e...